SIC 5912
Retail-Drug Stores and Proprietary Stores
5 companies
Total revenue (latest)
$403.76B
Total net income
$1.80B
Trimmed avg net margin
-35.0%
Median net margin
-2.8%
5-year industry trend
Total revenue summed across 4 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1CVSCVS HEALTH Corp
$122.42B cap · 0.4% margin · as of 2025-12-31
$402.07B
revenue
- 2GRDNGuardian Pharmacy Services, Inc.
3.4% margin · $49.2M NI · as of 2025-12-31
$1.45B
revenue
- 3PETSPETMED EXPRESS INC
$38.9M cap · -2.8% margin · as of 2025-12-31
$227.0M
revenue
- 4CANNTREES Corp (Colorado)
$2.2M cap · -39.0% margin · as of 2023-12-31
$18.1M
revenue
- 5AIXNAiXin Life International, Inc.
$8.0M cap · -137.1% margin · as of 2025-12-31
$1.5M
revenue
Insider activity in this industry · last 12 months
Insider buying
$1.1M
Insider selling
$778.8M
Net flow
−$777.7M
Distinct insiders
15
Open-market trades summed across all 2 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
About the Retail-Drug Stores and Proprietary Stores industry on ActaClear
ActaClear tracks 5 US-listed public companies classified under SEC SIC code 5912 (Retail-Drug Stores and Proprietary Stores). Combined latest-period revenue across the sector is $403.76B, with a median net margin of -2.8% per company.
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.